Reports Q3 revenue $1.08B, consensus $1.07B. “I am pleased to announce that the Illumina (ILMN) team delivered Q325 results that exceeded the high-end of our guidance range for revenue and earnings, driven by revenue acceleration in clinical, our largest market segment,” said Jacob Thaysen, Chief Executive Officer. “During the quarter, we returned to growth ex-China and are executing on our strategic pillars that support our long-range financial targets.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN: